PROM1 and colonic neoplasm: In this study, to determine the role of CD133 in colon cancer, we established a CD133knockout colon cancer cell line using CRISPR-Cas9 gene editing system and analyzed whether CD133 knockout contributed to attenuate the abilities of colon cancer cells, including colony formation, cell proliferation, migration, and invasion.